Takaisin Tulosta

Raskauden ehkäisy, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimtus
17.3.2025

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Raskauden ehkäisy «Raskauden ehkäisy»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Abdul Sultan A, Tata LJ, Grainge MJ, ym. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis. PLoS One 2013;8(7):e70310 «PMID: 23922975»PubMed
  2. Abdulrehman J, Elbaz C, Aziz D, ym. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol 2022;199(1):130-142 «PMID: 35877546»PubMed
  3. Akers AY, Steinway C, Sonalkar S, ym. Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women. Obstet Gynecol 2017;130(4):795-802 «PMID: 28885425»PubMed
  4. Aksoy H, Aksoy Ü, Ozyurt S, ym. Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. J Fam Plann Reprod Health Care 2016;42(2):83-7 «PMID: 25759418»PubMed
  5. Almstedt HC, Cook MM, Bramble LF, ym. Oral contraceptive use, bone mineral density, and bone turnover markers over 12 months in college-aged females. J Bone Miner Metab 2020;38(4):544-554 «PMID: 31983034»PubMed
  6. Andersson K, Ryde-Blomqvist E, Lindell K, ym. Perforations with intrauterine devices. Report from a Swedish survey. Contraception 1998;57(4):251-5 «PMID: 9649917»PubMed
  7. Arowojolu AO, Gallo MF, Lopez LM, ym. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012;2012(7):CD004425 «PMID: 22786490»PubMed
  8. Auyeung AB, Almejally A, Alsaggar F, ym. Incidence of Post-Vasectomy Pain: Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2020;17(5): «PMID: 32164161»PubMed
  9. Averbach S, Kakaire O, McDiehl R, ym. The effect of immediate postpartum levonorgestrel contraceptive implant use on breastfeeding and infant growth: a randomized controlled trial. Contraception 2019;99(2):87-93 «PMID: 30408456»PubMed
  10. Bahamondes L, Bahamondes MV, Modesto W, ym. Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth. Fertil Steril 2013;100(2):445-50 «PMID: 23623474»PubMed
  11. Bahamondes L, Brache V, Ali M, ym. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement. Contraception 2018;98(3):181-187 «PMID: 29777663»PubMed
  12. Bain E, Wilson A, Tooher R, ym. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev 2014;(2):CD001689 «PMID: 24519568»PubMed
  13. Barnett C, Moehner S, Do Minh T, ym. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study. Eur J Contracept Reprod Health Care 2017;22(6):424-428 «PMID: 29322856»PubMed
  14. Barrionuevo P, Nabhan M, Altayar O, ym. Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. J Clin Endocrinol Metab 2018;103(4):1258-1264 «PMID: 29522176»PubMed
  15. Bednarek PH, Creinin MD, Reeves MF, ym. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception 2015;91(3):193-7 «PMID: 25487172»PubMed
  16. Bellows BK, Tak CR, Sanders JN, ym. Cost-effectiveness of emergency contraception options over 1 year. Am J Obstet Gynecol 2018;218(5):508.e1-508.e9 «PMID: 29409847»PubMed
  17. Brajic TS, Berger C, Schlammerl K, ym. Combined hormonal contraceptives use and bone mineral density changes in adolescent and young women in a prospective population-based Canada-wide observational study. J Musculoskelet Neuronal Interact 2018;18(2):227-236 «PMID: 29855445»PubMed
  18. Brown J, Crawford TJ, Datta S, ym. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2018;5(5):CD001019 «PMID: 29786828»PubMed
  19. Butwick AJ, Bentley J, Leonard SA, ym. Prepregnancy maternal body mass index and venous thromboembolism: a population-based cohort study. BJOG 2019;126(5):581-588 «PMID: 30500109»PubMed
  20. Caliskan E, Oztürk N, Dilbaz BO, ym. Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 2003;8(3):150-5 «PMID: 14667326»PubMed
  21. Champaloux SW, Tepper NK, Monsour M, ym. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol 2017;216(5):489.e1-489.e7 «PMID: 28034652»PubMed
  22. Cibula D, Skrenkova J, Hill M, ym. Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. Eur J Endocrinol 2012;166(6):1003-11 «PMID: 22436400»PubMed
  23. Clark MK, Sowers M, Levy B, ym. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2006;86(5):1466-74 «PMID: 16996507»PubMed
  24. Cleland K, Zhu H, Goldstuck N, ym. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012;27(7):1994-2000 «PMID: 22570193»PubMed
  25. Cockrum RH, Soo J, Ham SA, ym. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol 2022;140(3):477-487 «PMID: 35926206»PubMed
  26. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, ym. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008;371(9609):303-14 «PMID: 18294997»PubMed
  27. Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol 2015;16(9):1061-1070 «PMID: 26254030»PubMed
  28. Conti JA, Lerma K, Schneyer RJ, ym. Self-administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial. Am J Obstet Gynecol 2019;220(2):177.e1-177.e7 «PMID: 30444982»PubMed
  29. Cook LA, Van Vliet HA, Lopez LM, ym. Vasectomy occlusion techniques for male sterilization. Cochrane Database Syst Rev 2014;2014(3):CD003991 «PMID: 24683020»PubMed
  30. Creinin MD, Schreiber CA, Turok DK, ym. Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. Am J Obstet Gynecol 2022;227(6):871.e1-871.e7 «PMID: 35569516»PubMed
  31. Cromer BA, Bonny AE, Stager M, ym. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril 2008;90(6):2060-7 «PMID: 18222431»PubMed
  32. de Bastos M, Stegeman BH, Rosendaal FR, ym. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014;2014(3):CD010813 «PMID: 24590565»PubMed
  33. De Nadai MN, Poli-Neto OB, Franceschini SA, ym. Intracervical block for levonorgestrel-releasing intrauterine system placement among nulligravid women: a randomized double-blind controlled trial. Am J Obstet Gynecol 2020;222(3):245.e1-245.e10 «PMID: 31541635»PubMed
  34. de Oliveira ECF, Baêta T, Brant APC, ym. Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial. BMC Womens Health 2021;21(1):377 «PMID: 34715839»PubMed
  35. Didembourg M, Locquet M, Raskin L, ym. Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database. Contraception 2025;142():110727 «PMID: 39424122»PubMed
  36. Dou W, Huang Y, Liu X, ym. Associations of Oral Contraceptive Use With Cardiovascular Disease and All-Cause Death: Evidence From the UK Biobank Cohort Study. J Am Heart Assoc 2023;12(16):e030105 «PMID: 37581386»PubMed
  37. Douxfils J, Raskin L, Didembourg M, ym. Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis. Front Endocrinol (Lausanne) 2024;15():1428597 «PMID: 39220361»PubMed
  38. Dragoman MV, Simmons KB, Paulen ME, ym. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review. Contraception 2017;95(2):117-129 «PMID: 27823942»PubMed
  39. Dragoman MV, Tepper NK, Fu R, ym. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet 2018;141(3):287-294 «PMID: 29388678»PubMed
  40. Edelman A, Micks E, Gallo MF, ym. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 2014;2014(7):CD004695 «PMID: 25072731»PubMed
  41. Etminan M, Takkouche B, Isorna FC, ym. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330(7482):63 «PMID: 15596418»PubMed
  42. Faculty of Sexual and Reproductive Healthcare. FSRH guideline – Emergency contraception. London: Faculty of Sexual and Reproductive Healthcare, March 2017, amended July 2023.
  43. Farley TM, Meirik O, Chang CL, ym. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health 1998;52(12):775-85 «PMID: 10396518»PubMed
  44. Festin MPR, Peregoudov A, Seuc A, ym. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies. Contraception 2017;95(1):50-54 «PMID: 27527670»PubMed
  45. Fraison E, Kostova E, Moran LJ, ym. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev 2020;8(8):CD005552 «PMID: 32794179»PubMed
  46. Fraser IS, Jensen J, Schaefers M, ym. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest. Contraception 2012;86(2):96-101 «PMID: 22240178»PubMed
  47. French R, Van Vliet H, Cowan F, ym. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004;2004(3):CD001776 «PMID: 15266453»PubMed
  48. Gai L, Jia Y, Zhang M, ym. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women. Contraception 2012;86(4):332-6 «PMID: 22364818»PubMed
  49. Galambosi PJ, Gissler M, Kaaja RJ, ym. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand 2017;96(7):852-861 «PMID: 28369660»PubMed
  50. Gallo MF, Grimes DA, Lopez LM, ym. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2006;2006(1):CD003550 «PMID: 16437459»PubMed
  51. Gallo MF, Lopez LM, Grimes DA, ym. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014;2014(1):CD003987 «PMID: 24477630»PubMed
  52. Gallo MF, Nanda K, Grimes DA, ym. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2013;2013(8):CD003989 «PMID: 23904209»PubMed
  53. Gariepy AM, Lewis C, Zuckerman D, ym. Comparative effectiveness of hysteroscopic and laparoscopic sterilization for women: a retrospective cohort study. Fertil Steril 2022;117(6):1322-1331 «PMID: 35428480»PubMed
  54. Goshtasebi A, Subotic Brajic T, Scholes D, ym. Adolescent use of combined hormonal contraception and peak bone mineral density accrual: A meta-analysis of international prospective controlled studies. Clin Endocrinol (Oxf) 2019;90(4):517-524 «PMID: 30614555»PubMed
  55. Goueth RC, Maki KG, Babatunde A, ym. Effects of technology-based contraceptive decision aids: a systematic review and meta-analysis. Am J Obstet Gynecol 2022;227(5):705-713.e9 «PMID: 35779590»PubMed
  56. Grandi G, Barra F, Ferrero S, ym. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care 2019;24(1):61-70 «PMID: 30664383»PubMed
  57. Hadji P, Neulen J, Schaudig K, ym. Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 μg) and levonorgestrel (150 μg) in a randomized controlled trial. Gynecol Endocrinol 2020;36(6):513-520 «PMID: 32064971»PubMed
  58. Hannaford PC, Selvaraj S, Elliott AM, ym. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 2007;335(7621):651 «PMID: 17855280»PubMed
  59. Harel Z, Johnson CC, Gold MA, ym. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010;81(4):281-91 «PMID: 20227543»PubMed
  60. Heinemann K, Reed S, Moehner S, ym. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception 2015;91(4):280-3 «PMID: 25601350»PubMed
  61. Heinemann K, Reed S, Moehner S, ym. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 2015;91(4):274-9 «PMID: 25601352»PubMed
  62. Heit JA, Kobbervig CE, James AH, ym. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143(10):697-706 «PMID: 16287790»PubMed
  63. Henkel A, Lerma K, Reyes G, ym. Lactogenesis and breastfeeding after immediate vs delayed birth-hospitalization insertion of etonogestrel contraceptive implant: a noninferiority trial. Am J Obstet Gynecol 2023;228(1):55.e1-55.e9 «PMID: 35964661»PubMed
  64. Horton LG, Simmons KB, Curtis KM. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review. Contraception 2016;94(6):590-604 «PMID: 27263039»PubMed
  65. Iversen L, Fielding S, Lidegaard Ø, ym. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 2018;362():k3609 «PMID: 30257920»PubMed
  66. Iversen L, Sivasubramaniam S, Lee AJ, ym. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study. Am J Obstet Gynecol 2017;216(6):580.e1-580.e9 «PMID: 28188769»PubMed
  67. Jaisamrarn U, Santibenchakul S. A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial. Contracept Reprod Med 2018;3():5 «PMID: 29662684»PubMed
  68. Jensen JT, Lukkari-Lax E, Schulze A, ym. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial. Am J Obstet Gynecol 2022;227(6):873.e1-873.e12 «PMID: 36096186»PubMed
  69. Jensen JT, Schlaff W, Gordon K. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence. Fertil Steril 2018;110(1):137-152.e1 «PMID: 29937152»PubMed
  70. Kaislasuo J, Suhonen S, Gissler M, ym. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study. Hum Reprod 2012;27(9):2658-63 «PMID: 22763376»PubMed
  71. Kamel H, Navi BB, Sriram N, ym. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014;370(14):1307-15 «PMID: 24524551»PubMed
  72. Karasu Y, Cömert DK, Karadağ B, ym. Lidocaine for pain control during intrauterine device insertion. J Obstet Gynaecol Res 2017;43(6):1061-1066 «PMID: 28503818»PubMed
  73. Karlsson T, Johansson T, Höglund J, ym. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers. Cancer Res 2021;81(4):1153-1162 «PMID: 33334812»PubMed
  74. Koster T, Small RA, Rosendaal FR, ym. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties. J Intern Med 1995;238(1):31-7 «PMID: 7608644»PubMed
  75. Kraft MZ, Rojczyk P, Weiss T, ym. Symptoms of mental disorders and oral contraception use: A systematic review and meta-analysis. Front Neuroendocrinol 2024;72():101111 «PMID: 37967755»PubMed
  76. Lange HL, Manos BE, Gothard MD, ym. Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate. J Pediatr Adolesc Gynecol 2017;30(2):169-175 «PMID: 27789350»PubMed
  77. Lawrie TA, Kulier R, Nardin JM. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev 2016;2016(8):CD003034 «PMID: 27494193»PubMed
  78. Le Moigne E, Delluc A, Tromeur C, ym. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study. Thromb Res 2013;132(1):51-5 «PMID: 23786893»PubMed
  79. Lethaby A, Wise MR, Weterings MA, ym. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev 2019;2(2):CD000154 «PMID: 30742315»PubMed
  80. Li J, Panucci G, Moeny D, ym. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database. JAMA Intern Med 2018;178(11):1482-1488 «PMID: 30285041»PubMed
  81. Li RHW, Lo SST, Gemzell-Danielsson K, ym. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet 2023;402(10405):851-858 «PMID: 37597523»PubMed
  82. Lidegaard Ø, Løkkegaard E, Jensen A, ym. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366(24):2257-66 «PMID: 22693997»PubMed
  83. Lopez LM, Bernholc A, Chen M, ym. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2016;2016(8):CD008452 «PMID: 27537097»PubMed
  84. Lopez LM, Bernholc A, Zeng Y, ym. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2015;2015(7):CD007373 «PMID: 26222246»PubMed
  85. Lopez LM, Chen M, Mullins Long S, ym. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 2015;2015(7):CD009849 «PMID: 26195091»PubMed
  86. Lopez LM, Grey TW, Stuebe AM, ym. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev 2015;2015(3):CD003988 «PMID: 25793657»PubMed
  87. Lopez LM, Grimes DA, Schulz KF, ym. Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 2014;2014(6):CD006033 «PMID: 24960023»PubMed
  88. Lopez LM, Ramesh S, Chen M, ym. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016;2016(8):CD008815 «PMID: 27567593»PubMed
  89. Jianzhong Z, Ma Y, Weihua L. Strategies for communicating contraceptive effectiveness. Public Health Nurs 2014;31(5):438-40 «PMID: 24612358»PubMed
  90. Ma S, Song SJ. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2023;6(6):CD006586 «PMID: 37365881»PubMed
  91. Mack N, Crawford TJ, Guise JM, ym. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception. Cochrane Database Syst Rev 2019;4(4):CD004317 «PMID: 31013349»PubMed
  92. Mao J, Guiahi M, Chudnoff S, ym. Seven-Year Outcomes After Hysteroscopic and Laparoscopic Sterilizations. Obstet Gynecol 2019;133(2):323-331 «PMID: 30633141»PubMed
  93. McNicholas C, Swor E, Wan L, ym. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration. Am J Obstet Gynecol 2017;216(6):586.e1-586.e6 «PMID: 28147241»PubMed
  94. Meaidi A, Mascolo A, Sessa M, ym. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study. BMJ 2023;382():e074450 «PMID: 37673431»PubMed
  95. Mills K, Marchand G, Sainz K, ym. Salpingectomy vs tubal ligation for sterilization: a systematic review and meta-analysis. Am J Obstet Gynecol 2021;224(3):258-265.e4 «PMID: 32941790»PubMed
  96. Mody SK, Farala JP, Jimenez B, ym. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol 2018;132(3):575-582 «PMID: 30095776»PubMed
  97. Nappi RE, Lete I, Lee LK, ym. Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey. BMC Womens Health 2018;18(1):22 «PMID: 29347935»PubMed
  98. Nappi RE, Lobo Abascal P, Hsieh J, ym. Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval. Int J Womens Health 2017;9():739-747 «PMID: 29042818»PubMed
  99. Ngo LL, Braaten KP, Eichen E, ym. Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. Obstet Gynecol 2016;128(6):1306-1313 «PMID: 27824753»PubMed
  100. Oedingen C, Scholz S, Razum O. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose. Thromb Res 2018;165():68-78 «PMID: 29573722»PubMed
  101. O'Neil-Callahan M, Peipert JF, Zhao Q, ym. Twenty-four-month continuation of reversible contraception. Obstet Gynecol 2013;122(5):1083-1091 «PMID: 24104781»PubMed
  102. Oringanje C, Meremikwu MM, Eko H, ym. Interventions for preventing unintended pregnancies among adolescents. Cochrane Database Syst Rev 2016;2(2):CD005215 «PMID: 26839116»PubMed
  103. Panichyawat N, Mongkornthong T, Wongwananuruk T, ym. 10% lidocaine spray for pain control during intrauterine device insertion: a randomised, double-blind, placebo-controlled trial. BMJ Sex Reprod Health 2021;47(3):159-165 «PMID: 32591417»PubMed
  104. Park JE, Park Y, Yuk JS. Incidence of and risk factors for thromboembolism during pregnancy and postpartum: A 10-year nationwide population-based study. Taiwan J Obstet Gynecol 2021;60(1):103-110 «PMID: 33494981»PubMed
  105. Perez-Lopez FR, Martinez-Dominguez SJ, Perez-Roncero GR, ym. Uterine or paracervical lidocaine application for pain control during intrauterine contraceptive device insertion: a meta-analysis of randomised controlled trials. Eur J Contracept Reprod Health Care 2018;23(3):207-217 «PMID: 29792756»PubMed
  106. Perinpanathan T, Maiya S, van Velthoven MHH, ym. Mobile phone-based interventions for improving contraception use. Cochrane Database Syst Rev 2023;7(7):CD011159 «PMID: 37458240»PubMed
  107. Pikkarainen E, Lehtonen-Veromaa M, Möttönen T, ym. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Contraception 2008;78(3):226-31 «PMID: 18692613»PubMed
  108. Podfigurna A, Meczekalski B, Petraglia F, ym. Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone). J Endocrinol Invest 2020;43(4):483-492 «PMID: 31654312»PubMed
  109. Polatti F, Perotti F, Filippa N, ym. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 1995;51(4):221-4 «PMID: 7796586»PubMed
  110. Poprzeczny AJ, Stocking K, Showell M, ym. Patient Decision Aids to Facilitate Shared Decision Making in Obstetrics and Gynecology: A Systematic Review and Meta-analysis. Obstet Gynecol 2020;135(2):444-451 «PMID: 31923056»PubMed
  111. Potter W, Burt G, Walsh T. Clinical breakage, slippage and acceptability of two commercial ultra-thin polyurethane male condoms compared to a commercial thin latex condom: a randomised, masked, 3 way crossover, multi centre controlled study (SAGCS 2). Reprod Health 2024;21(1):128 «PMID: 39232840»PubMed
  112. Ramanadhan S, Goldstuck N, Henderson JT, ym. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception. Cochrane Database Syst Rev 2023;2(2):CD013744 «PMID: 36847591»PubMed
  113. Ramos-Rivera M, Averbach S, Selvaduray P, ym. Complications after interval postpartum intrauterine device insertion. Am J Obstet Gynecol 2022;226(1):95.e1-95.e8 «PMID: 34461075»PubMed
  114. Roach RE, Helmerhorst FM, Lijfering WM, ym. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015;2015(8):CD011054 «PMID: 26310586»PubMed
  115. Rowe P, Farley T, Peregoudov A, ym. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A. Contraception 2016;93(6):498-506 «PMID: 26916172»PubMed
  116. Sacco S, Merki-Feld GS, Ægidius KL, ym. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 2017;18(1):108 «PMID: 29086160»PubMed
  117. Samy A, Abbas AM, Mahmoud M, ym. Evaluating different pain lowering medications during intrauterine device insertion: a systematic review and network meta-analysis. Fertil Steril 2019;111(3):553-561.e4 «PMID: 30611553»PubMed
  118. Schink T, Princk C, Braitmaier M, ym. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data. BJOG 2022;129(13):2107-2116 «PMID: 35876787»PubMed
  119. Schroll JB, Black AY, Farquhar C, ym. Combined oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev 2023;7(7):CD002120 «PMID: 37523477»PubMed
  120. Schürks M, Rist PM, Bigal ME, ym. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339():b3914 «PMID: 19861375»PubMed
  121. Shen J, Che Y, Showell E, ym. Interventions for emergency contraception. Cochrane Database Syst Rev 2017;8(8):CD001324 «PMID: 28766313»PubMed
  122. Shen J, Che Y, Showell E, ym. Interventions for emergency contraception. Cochrane Database Syst Rev 2019;1(1):CD001324 «PMID: 30661244»PubMed
  123. Silva Dos Santos PN, Madden T, Omvig K, ym. Changes in body composition in women using long-acting reversible contraception. Contraception 2017;95(4):382-389 «PMID: 28041992»PubMed
  124. Smith K, Byrne, Castaño JM, ym. Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Clin Oncol 2017;35(12):1297-1303 «PMID: 28375714»PubMed
  125. Spector JT, Kahn SR, Jones MR, ym. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010;123(7):612-24 «PMID: 20493462»PubMed
  126. Taneepanichskul S, Reinprayoon D, Thaithumyanon P, ym. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006;73(4):368-71 «PMID: 16531169»PubMed
  127. Tepper NK, Boulet SL, Whiteman MK, ym. Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol 2014;123(5):987-996 «PMID: 24785851»PubMed
  128. Tepper NK, Phillips SJ, Kapp N, ym. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review. Contraception 2016;94(3):262-74 «PMID: 26002804»PubMed
  129. The EMA’s Pharmacovigilance Risk Assessment Committee Pharmacovigilance Risk Assessment Committee (PRAC). PRAC confirms that benefits of all combined hormonal contraceptives (CHCs) continue to outweigh risks EMA/607314/2013.
  130. Turok DK, Gero A, Simmons RG, ym. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med 2021;384(4):335-344 «PMID: 33503342»PubMed
  131. Turok DK, Leeman L, Sanders JN, ym. Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial. Am J Obstet Gynecol 2017;217(6):665.e1-665.e8 «PMID: 28842126»PubMed
  132. Van der Wijden C, Manion C. Lactational amenorrhoea method for family planning. Cochrane Database Syst Rev 2015;2015(10):CD001329 «PMID: 26457821»PubMed
  133. van Grootheest K, Sachs B, Harrison-Woolrych M, ym. Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres. Drug Saf 2011;34(1):83-8 «PMID: 21142273»PubMed
  134. van Vlijmen EF, Wiewel-Verschueren S, Monster TB, ym. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 2016;14(7):1393-403 «PMID: 27121914»PubMed
  135. van Zuuren EJ, Fedorowicz Z, Carter B, ym. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev 2015;2015(4):CD010334 «PMID: 25918921»PubMed
  136. Virkus RA, Løkkegaard EC, Bergholt T, ym. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005. A national cohort study. Thromb Haemost 2011;106(2):304-9 «PMID: 21713323»PubMed
  137. Weill A, Dalichampt M, Raguideau F, ym. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ 2016;353():i2002 «PMID: 27164970»PubMed
  138. Wiegers HMG, Knijp J, van Es N, ym. Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis. J Thromb Haemost 2022;20(5):1158-1165 «PMID: 35108438»PubMed
  139. Winner B, Peipert JF, Zhao Q, ym. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366(21):1998-2007 «PMID: 22621627»PubMed
  140. Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception 2018;97(6):478-489 «PMID: 29496297»PubMed
  141. Yamazaki M, Dwyer K, Sobhan M, ym. Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis. Contraception 2015;92(5):445-52 «PMID: 26247330»PubMed
Artikkelin tunnus: nix03529 (050.104)
© 2025 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit